BioSpace News Archive

Indaptus Therapeutics, Inc., announced that Jeffrey A. Meckler, Chief Executive Officer of Indaptus, will present a corporate overview at the JMP Securities Life Sciences Conference on Thursday, June 16, 2022 at 2:30 p.m. ET in New York City.

Aptevo Therapeutics Inc. today announced new remission data on four additional patients.

Bright Uro, a medical device company with a mission to transform care for lower urinary tract symptoms (LUTS) through innovations in urodynamics, announced today the launch of the company with $4 million in seed financing from Academy Investor Network, Fred Moll, and several other prominent angel investors.

Relation Therapeutics announced today that it had raised a $25 million investment and hired a Chief Executive Officer and Chief Technology Officer.

BioNTech SE (Nasdaq: BNTX, “BioNTech”) will welcome its African partners for the first time on the African continent and provide an update on the joint establishment of mRNA manufacturing facilities and vaccine development plans.

Annovis Bio’s Current Intellectual Property Portfolio Covers the Use of Buntanetap, the Company’s Lead Compound, to Treat Neurodegenerative Diseases.

Wilmington, Delaware, United States: The concept of medical tourism has opened the door for accessibility to highly advanced medical technologies and broader treatment options to major population around the world.

Since an escalating number of patients are being diagnosed with cancer every day, the global demand for gene therapy and antisense drugs is bound to multiply.

CHARM Therapeutics (“CHARM”, “The Company”), a 3D deep-learning research company discovering and developing transformational medicines founded by David Baker, Ph.D. and Laksh Aithani, announces today a $50M Series A financing co-led by F-Prime Capital and OrbiMed, with General Catalyst, Khosla Ventures, Braavos and Axial also participating.

Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, will host a webinar focused on the current treatment landscape and unmet medical need for patients with chronic low back pain due to degenerative disc disease, a condition associated with local inflammation in the disc.